Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Drug Research
Drug Discovery & Development
Return to: PBR Home | Drug Research | Drug Discovery & Development
Search Refinements
Search Results: Drug Discovery & Development
1-15 of 5022 results
Ferrer completes second Phase III trial of impetigo treatment ozenoxacin
By PBR Staff Writer
Canada-based Cipher Pharmaceuticals' partner Ferrer International has completed the second Phase III clinical trial for ozenoxacin, a topical treatment for adult and paediatric patients with impetigo, a highly contagious bacterial skin infection.
Drug Research > Drug Discovery & Development > News
Eisai and Halozyme to evaluate combination drug for treatment of metastatic breast cancer
Eisai and Halozyme Therapeutics have agreed to evaluate the combination of their drugs, Halaven (eribulin) and PEGPH20 (PEGylated recombinant human hyaluronidase), respectively, in the treatment of first line HER2-negative metastatic breast cancer.
Drug Research > Drug Discovery & Development > News
Flexion completes patient enrollment in FX006 Phase III trial for osteoarthritis of the knee
By PBR Staff Writer
US-based pharmaceutical firm Flexion Therapeutics has completed enrollment of 486 patients in the Phase III clinical trial of its lead compound FX006 about three months earlier than anticipated.
Drug Research > Drug Discovery & Development > News
Kyowa Hakko Kirin, Bristol-Myers enter into immuno-oncology clinical collaboration
By PBR Staff Writer
Kyowa Hakko Kirin and Bristol-Myers Squibb have entered into a clinical trial collaboration agreement to conduct a Phase I/II combination trial with mogamulizumab, an anti-CCR4 antibody and Opdivo (nivolumab), a PD-1 immune checkpoint inhibitor to treat advanced or metastatic solid tumors.
Drug Research > Drug Discovery & Development > News
Sanofi's first Lixilan Phase III trial meets primary endpoint
Sanofi announced that the LixiLan-O Phase III clinical trial met its primary objective in patients with type 2 diabetes treated with metformin.
Drug Research > Drug Discovery & Development > News
DNDi, Takeda to develop new treatment for visceral leishmaniasis
By PBR Staff Writer
Switzerland-based Drugs for Neglected Diseases initiative (DNDi) and Takeda Pharmaceutical have signed an agreement to collaborate in the 'Lead Optimization Program' to discover the best compound among aminopyrazole series for developing a new treatment for visceral leishmaniasis (VL).
Drug Research > Drug Discovery & Development > News
China's Yabao and Lawson complete discovery validation work of annexin A5-based products
By PBR Staff Writer
China-based Yabao Pharmaceutical and Lawson Health Research Institute (Lawson) have completed the discovery validation work of products based on annexin A5 and moved the program into preclinical development.
Drug Research > Drug Discovery & Development > News
Truly Parallel - Cell Culture
| By Eppendorf
DASGIP® Bioreactor Systems for Cell Culture Applications.
Drug Research > Drug Discovery & Development > White Papers
Product Brochure: Most Compact
| By Eppendorf
DASbox® Mini Bioreactor System for Cell Culture and Microbiology.
Drug Research > Drug Discovery & Development > White Papers
Invion, Hovione sign joint development and licensing deal for inhaled Zafirlukast
Australian drug development company Invion has secured a commitment from Hovione Scientia Limited, an international pharmaceutical company expert in inhalation development and manufacturing, to progress development of inhaled INV104 (zafirlukast) as a potential new treatment for asthma.
Drug Research > Drug Discovery & Development > News
Eddingpharm to begin Phase I trial of Brinavess in China
By PBR Staff Writer
Eddingpharm, the Chinese development and commercialization partner of Cardiome Pharma, is planning to start a Phase I trial of Brinavess to support regulatory approval in China.
Drug Research > Drug Discovery & Development > News
Erytech reports positive results from Phase II trial of ERY-ASP in pancreatic cancer patients
By PBR Staff Writer
French biopharmaceutical firm Erytech Pharma has reported positive results from a Phase II trial of its lead product candidate ERY-ASP in patients with pancreatic cancer.
Drug Research > Drug Discovery & Development > News
Bristol-Myers's Phase III RCC trial of Opdivo shows superior overall survival over everolimus
By PBR Staff Writer
Bristol-Myers Squibb has stopped a Phase III trial (CheckMate -025) evaluating Opdivo (nivolumab) versus everolimus in previously-treated patients with advanced or metastatic renal cell carcinoma (RCC).
Drug Research > Drug Discovery & Development > News

PBR Supplier Recommendations

Therapure Biopharma - Contract Protein Development and Manufacturing
Therapure Biopharma is a Contract Development and Manufacturing Organization (CDMO) that specializes in the development, scale up and manufacture of complex biologics. ... Drug Research > Drug Discovery & Development > Suppliers
Vetter Pharma International - High-Quality Aseptically Pre-Filled Injection Systems
From preclinical development through commercial supply.... Drug Research > Drug Discovery & Development > Suppliers
ERT - Getting it done. Right.
ERT is a leading global provider of high-quality patient safety and efficacy endpoint data collection solutions for use by biopharmaceutical companies during clinical drug development. ERT delivers a combination of technology, services, and consulting that increase the accuracy and reliability of patient data and improve the efficiency of the clinical development process throughout the product lifecycle.... Drug Research > Drug Discovery & Development > Suppliers
Eppendorf - We Know Bioprocessing
Eppendorf is a leading life science company that develops and sells instruments, consumables, and services for liquid-, sample-, and cell handling in laboratories worldwide. Its product range includes pipettes and automated pipetting systems, dispensers, centrifuges, mixers, spectrometers, and DNA amplification equipment as well as ultra-low temperature freezers, fermentors, bioreactors, CO² incubators, shakers, and cell manipulation systems. Consumables such as pipette tips, test tubes, microtiter plates, and disposable bioreactors complement the range of highest-quality premium products.... Drug Research > Drug Discovery & Development > Suppliers
Biovian - cGMP Contract Manufacturing of Biopharmaceuticals
Biovian is a dynamic and effective new generation one-stop-shop CMO in cGMP contract manufacturing of biopharmaceuticals. Biovian's services cover the full range from antigen isolation, expression, vector construction, cell line cultivation, cGMP protein purification to product fill and finish.... Drug Research > Drug Discovery & Development > Suppliers
See more

PBR White Paper Recommendations

Truly Parallel - Microbiology By Eppendorf
DASGIP® Bioreactor Systems for Microbiology.... Drug Research > Drug Discovery & Development > White Papers Truly Parallel - Cell Culture By Eppendorf
DASGIP® Bioreactor Systems for Cell Culture Applications.... Drug Research > Drug Discovery & Development > White Papers Product Brochure: Most Compact By Eppendorf
DASbox® Mini Bioreactor System for Cell Culture and Microbiology.... Drug Research > Drug Discovery & Development > White Papers Product Brochure: The Smarter Solution By Eppendorf
BioFlo® 320 bioprocess control station.... Drug Research > Drug Discovery & Development > White Papers All-Purpose Protein Sample QC Using a Novel Micro-Volume Platform with Spectral Content Profiling Software By Trinean
Accurate total protein quantitation of purified proteins, cell lysates, affinity-column fractions or other complex protein samples is crucial for robust biochemical testing during biopharmaceutical development as well as production. As the presence of chemicals doesn't allow simple A280 protein quantification, more labor-intensive alternatives for quantification are used. Examples are the colorimetric Bradford or BCA assay, which negate to a large extent the presence of contaminants but require multiple steps and show variation depending on the sample composition and time point of measuring within the ongoing reaction.... Drug Research > Drug Discovery & Development > White Papers See more
1-15 of 5022 results